180 Life Sciences Extends Rally After Revealing $349 Million Ethereum Reserve

Written by Emily J. Thompson, Senior Investment Analyst

ATNF%

Source: Benzinga

Updated: Aug 13 2025

0mins

Source: Benzinga

Company's Financial Strategy: 180 Life Sciences Corp. has increased its holdings to over $349 million in Ethereum (ETH) as part of a new treasury strategy, planning to rebrand as ETHZilla Corporation and implement an on-chain yield generation program.
Stock Performance: Following a significant private offering, shares of 180 Life Sciences surged by 32.52%, trading at $13.57, reflecting a substantial increase compared to its moving averages and previous trading levels.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

180 Life Sciences Extends Rally After Revealing $349 Million Ethereum Reserve

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Major U.S. Banks Exceed Earnings Expectations, JPMorgan and Bank of America Show Significant Year-over-Year Growth

Alphabet (GOOG) AI Breakthroughs Drive 80% Stock Surge

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch